Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 06 Aug 2026 for Enliven Therapeutics, Inc., €188k. Read the official filing
Filing timeline
BuySaleMika K. Derynck
Insider track record
Disclosed buys
0
Disclosed sells
1
Signal history
Mika K. Derynck: trading record in brief
Mika K. Derynck appears in our data through filings on Enliven Therapeutics, Inc. shares, published by SEC (Form 4). The record holds 5 filings, all for trades on 4 August 2026.
Every open-market trade on record is a sale: 1 sale worth €8.3M. Besides market trades, the filings include 4 option exercises.
The record was last updated on 6 August 2026 with an option exercise (€188k) in Enliven Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Mika K. Derynck
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
87,373 shares@ US$2.480.0065% mcap1.1% of flowCommon StockSEC:0001865125-26-000004:0
27,567 shares@ US$25.280.021% mcap3.4% of flowCommon StockSEC:0001865125-26-000004:1
23,364 shares@ US$14.850.010% mcap1.7% of flowCommon StockSEC:0001865125-26-000004:2
20,491 shares@ US$22.470.014% mcap2.2% of flowCommon StockSEC:0001865125-26-000004:3
158,795 shares@ US$60.21340.29% mcap46.6% of flowCommon StockSEC:0001865125-26-000004:4
5 of 5 declarations
